Population genomic screening of all young adults in Australia to detect familial hypercholesterolemia: a cost-effectiveness analysis

被引：0
|
作者：
Ademi, Z. [1 ]
Marquina, C. [1 ]
Lacaze, P. [1 ]
Tiller, J. [1 ]
Riaz, M. [1 ]
Sturm, A. C. [2 ]
Nelson, M. [1 ]
Ference, B. A. [3 ]
Pang, J. [4 ]
Watts, G. F. [4 ]
Nicholls, S. J. [1 ]
Zoungas, S. [1 ]
Liew, D. [1 ]
McNeil, J. [1 ]
机构：
[1] Monash Univ, Melbourne, Vic, Australia
[2] Genom Med Inst, Geisinger, MD USA
[3] Univ Cambridge, Cambridge, England
[4] Univ Western Australia, Perth, WA, Australia
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2727 / 2727
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States
    Chen, Christina X.
    Hay, Joel W.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 181 : 417 - 424
  • [22] Cost-Effectiveness Analysis of a Genetic Screening Program in the Close Relatives of Spanish Patients With Familial Hypercholesterolemia
    Oliva, Juan
    Lopez-Bastida, Julio
    Moreno, Santiago G.
    Mata, Pedro
    Alonso, Rodrigo
    REVISTA ESPANOLA DE CARDIOLOGIA, 2009, 62 (01): : 57 - 65
  • [23] COST-EFFECTIVENESS OF SCREENING AND MANAGEMENT STRATEGIES FOR FAMILIAL HYPERCHOLESTEROLEMIA IN THE UNITED STATES: AN UPDATE
    Zawadzki, N. K.
    Hay, J.
    Ahmed, C. D.
    Myers, K. D.
    Gidding, S. S.
    VALUE IN HEALTH, 2019, 22 : S333 - S333
  • [24] Population Genomic Screening for Three Common Hereditary Conditions A Cost-Effectiveness Analysis
    Guzauskas, Gregory F.
    Garbett, Shawn
    Zhou, Zilu
    Schildcrout, Jonathan S.
    Graves, John A.
    Williams, Marc S.
    Hao, Jing
    Jones, Laney K.
    Spencer, Scott J.
    Jiang, Shangqing
    Veenstra, David L.
    Peterson, Josh F.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (05) : 585 - +
  • [25] RE-EVALUATION OF THE COST-EFFECTIVENESS OF CASCADE SCREENING AND TREATMENT STRATEGIES FOR ADULTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE UNITED STATES
    Zawadzki, N.
    Hay, J. W.
    Ahmed, C. D.
    Myers, K. D.
    Wilemon, K.
    McGowan, M. P.
    Gidding, S. S.
    Knowles, J. W.
    VALUE IN HEALTH, 2020, 23 : S2 - S2
  • [26] Screening for familial hypertrophic cardiomyopathy: a cost-effectiveness analysis
    Hendrix, Anneke
    Mosterd, Arend
    Doevendans, Pieter
    Post, Jan
    Bots, Michiel
    Greving, Jacoba
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 (06) : I - I
  • [27] SCREENING ADOLESCENTS AND YOUNG ADULTS FOR HIV IN THE UNITED STATES: A COST-EFFECTIVENESS ANALYSIS
    Neilan, Anne
    Dunville, Richard
    Ocfemia, M. Cheryl Banez
    Salomon, Joshua
    Francke, Jordan
    Wang, Li Yan
    Bulteel, Alex
    Hsu, Kathy
    DiNenno, Elizabeth
    Parker, Robert
    Walensky, Rochelle
    Freedberg, Kenneth
    Ciaranello, Andrea
    JOURNAL OF ADOLESCENT HEALTH, 2017, 60 (02) : S18 - S18
  • [28] COST-EFFECTIVENESS OF EVOLOCUMAB IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN BELGIUM
    Descamps, O. S.
    Van Hout, B.
    Lindgren, P.
    Villa, G.
    Urbich, M.
    Fonarow, G. C.
    ATHEROSCLEROSIS, 2020, 315 : E36 - E36
  • [29] COST-EFFECTIVENESS OF MAMMOGRAPHIC SCREENING IN AUSTRALIA
    CARTER, R
    GLASZIOU, P
    VANOORTMARSSEN, G
    DEKONING, H
    STEVENSON, C
    SALKELD, G
    BOER, R
    AUSTRALIAN JOURNAL OF PUBLIC HEALTH, 1993, 17 (01): : 42 - 50
  • [30] Screening for familial intracranial aneurysms: Decision and cost-effectiveness analysis
    Takao, Hidemasa
    Nojo, Takeshi
    Ohtomo, Kuni
    ACADEMIC RADIOLOGY, 2008, 15 (04) : 462 - 471
12345